Skip to content

Harrow HROW Change in AP

Change in AP at other companies

AbbVie logo
AbbVieABBV
-$1.59B-129%
Bausch + Lomb logo
Bausch + LombBLCO
-$94M-309%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$3.72M+53,029%
Viatris logo
ViatrisVTRS
$32.7M-67.8%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$150M-51.5%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$733K-128%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's change in AP?
Harrow (HROW) reported change in AP of $3.38M in Q1 2026.
How has Harrow's change in AP changed year-over-year?
Harrow's change in AP increased by 130.4% year-over-year, from -$11.1M to $3.38M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.